Global Roundup: Overland Pharma Launches in China to Provide Access to Breakthrough Therapies
The Pharma Data
DECEMBER 9, 2020
The aim of the research will be to create a TGS IVD platform by optimizing a multi-layer approach encompassing the initial sample and library preparation, state-of-the-art sequencing technologies and improved genotyping procedures. Amolyt has also acquired an option to license the identified candidates for future clinical development.
Let's personalize your content